Nektar Therapeutics (NKTR) — Free Cash Flow Generation Index
Nektar Therapeutics (NKTR) has a Free Cash Flow Generation Index of 1.00x as of June 2018. Free cash flow of $956.90 Million represents 1% of operating cash flow ($959.64 Million). See NKTR working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Nektar Therapeutics Free Cash Flow Generation Index (1997–2018)
Historical FCF Generation Index trend for Nektar Therapeutics across 4 annual periods. Explore Nektar Therapeutics cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Nektar Therapeutics (1997–2018)
Year-by-year Free Cash Flow Generation Index for Nektar Therapeutics. For the full company profile including market capitalisation, see NKTR market cap overview.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.98x | $703.98 Million | $718.21 Million | $14.24 Million | ▲ +104.6% |
| 2009 | 0.48x | $19.04 Million | $39.74 Million | $20.70 Million | ▼ -38.3% |
| 2007 | 0.78x | $113.51 Million | $146.30 Million | $32.80 Million | ▲ +131.5% |
| 1997 | -2.47x | $-12.28 Million | $4.98 Million | $17.26 Million | — |